Position in INSM
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,026,101
+$588,845 QoQ
Shares Held
18,506
+32.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Swiss Life Asset Management Ltd holds $100,695,940 across 59 Biotechnology names. INSM ranks #5 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
82,574 | $36,872,593 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
30,525 | $23,584,835 | |
| 3 | INCY |
Incyte Corp
|
96,083 | $9,043,331 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,734 | $7,852,868 | |
| 5 | INSM |
INSMED Inc
This page
|
18,506 | $3,026,101 | |
| 6 | MRNA |
Moderna, Inc.
|
25,661 | $1,303,578 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
12,779 | $1,242,757 | |
| 8 | EXEL |
Exelixis, Inc.
|
22,212 | $952,672 |
All Filings in INSM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,026,101 | 18,506 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,437,256 | 14,004 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,255,191 | 8,716 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $477,335 | 4,743 | Shares | Sole | 2025-12-02 | |
| 2025-03-31 | $200,184 | 2,624 | Shares | Sole | 2025-12-02 | |
| No filing history on record for this holder in this stock. | ||||||